Company intelligence / Profile preview

Affimed

Heidelberg/Mannheim*, Baden-Württemberg, Germanyaffimed.com ↗

Ownership: Public · AFMD
Employees: ~200
Development stage: Phase 1

Overview

Affimed’s clinical programs have shown promising efficacy and safety. Acimtamig combined with NK cells has demonstrated high objective response rates in heavily pretreated Hodgkin lymphoma patients with a manageable safety profile. AFM24 has shown compelling responses in refractory NSCLC patients, particularly those with wild-type EGFR. AFM28 has reached the final dose level in its escalation study for AML[3][5].

Therapeutic areas: Oncology
Modalities: Bispecific antibodies (Innate Cell Engagers/ICE®)Tetravalent bispecific antibodies (TandAb technology)
Industry: Biotech

Drug pipeline

9 assets

AFM24

8 more assets in the full pipeline.

Request access →

Partnerships

Artiva Biotherapeutics (“AlloNK” allogeneic NK cell therapy)[5]Select pharmaceutical companies—details not fully specified[1]

Financials

Market cap: $3M
Total revenue: $155K
Enterprise value: $-9.1M

Beyond the preview

Go deeper on Affimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Affimed.

Explore the full profile